These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 27456487)
21. The RasGAP-binding protein p62dok is a mediator of inhibitory FcgammaRIIB signals in B cells. Tamir I; Stolpa JC; Helgason CD; Nakamura K; Bruhns P; Daeron M; Cambier JC Immunity; 2000 Mar; 12(3):347-58. PubMed ID: 10755621 [TBL] [Abstract][Full Text] [Related]
22. Distribution of the src-homology-2-domain-containing inositol 5-phosphatase SHIP-2 in both non-haemopoietic and haemopoietic cells and possible involvement of SHIP-2 in negative signalling of B-cells. Muraille E; Pesesse X; Kuntz C; Erneux C Biochem J; 1999 Sep; 342 Pt 3(Pt 3):697-705. PubMed ID: 10477282 [TBL] [Abstract][Full Text] [Related]
23. Through an ITIM-independent mechanism the FcγRIIB blocks B cell activation by disrupting the colocalized microclustering of the B cell receptor and CD19. Xu L; Li G; Wang J; Fan Y; Wan Z; Zhang S; Shaheen S; Li J; Wang L; Yue C; Zhao Y; Wang F; Brzostowski J; Chen YH; Zheng W; Liu W J Immunol; 2014 Jun; 192(11):5179-91. PubMed ID: 24790152 [TBL] [Abstract][Full Text] [Related]
24. The X-linked lymphoproliferative syndrome gene product SAP regulates B cell function through the FcgammaRIIB receptor. Li C; Chung B; Tao J; Iosef C; Aoukaty A; Wang Y; Tan R; Li SS Cell Signal; 2008 Nov; 20(11):1960-7. PubMed ID: 18662772 [TBL] [Abstract][Full Text] [Related]
25. Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment. Haga CL; Ehrhardt GR; Boohaker RJ; Davis RS; Cooper MD Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9770-5. PubMed ID: 17522256 [TBL] [Abstract][Full Text] [Related]
26. Two distinct tyrosine-based motifs enable the inhibitory receptor FcgammaRIIB to cooperatively recruit the inositol phosphatases SHIP1/2 and the adapters Grb2/Grap. Isnardi I; Lesourne R; Bruhns P; Fridman WH; Cambier JC; Daëron M J Biol Chem; 2004 Dec; 279(50):51931-8. PubMed ID: 15456754 [TBL] [Abstract][Full Text] [Related]
27. Essential role for the C-terminal noncatalytic region of SHIP in FcgammaRIIB1-mediated inhibitory signaling. Aman MJ; Walk SF; March ME; Su HP; Carver DJ; Ravichandran KS Mol Cell Biol; 2000 May; 20(10):3576-89. PubMed ID: 10779347 [TBL] [Abstract][Full Text] [Related]
28. FcgammaRIIB-mediated inhibition of T-cell receptor signal transduction involves the phosphorylation of SH2-containing inositol 5-phosphatase (SHIP), dephosphorylation of the linker of activated T-cells (LAT) and inhibition of calcium mobilization. Jensen WA; Marschner S; Ott VL; Cambier JC Biochem Soc Trans; 2001 Nov; 29(Pt 6):840-6. PubMed ID: 11709085 [TBL] [Abstract][Full Text] [Related]
29. FcgammaRIIb-mediated negative regulation of BCR signalling is associated with the recruitment of the MAPkinase-phosphatase, Pac-1, and the 3'-inositol phosphatase, PTEN. Brown KS; Blair D; Reid SD; Nicholson EK; Harnett MM Cell Signal; 2004 Jan; 16(1):71-80. PubMed ID: 14607277 [TBL] [Abstract][Full Text] [Related]
30. Inhibitory receptor FcγRIIb mediates the effects of IgG on a phagosome acidification and a sequential dephosphorylation system comprising SHIPs and Inpp4a. Segawa T; Hazeki K; Nigorikawa K; Nukuda A; Tanizawa T; Miyamoto K; Morioka S; Hazeki O Innate Immun; 2017 May; 23(4):401-409. PubMed ID: 28409542 [TBL] [Abstract][Full Text] [Related]
31. Unique features of SHIP, SHP-1 and SHP-2 binding to FcgammaRIIb revealed by surface plasmon resonance analysis. Famiglietti SJ; Nakamura K; Cambier JC Immunol Lett; 1999 May; 68(1):35-40. PubMed ID: 10397153 [TBL] [Abstract][Full Text] [Related]
32. Heterologous regulation of chemokine receptor signaling by the lipid phosphatase SHIP in lymphocytes. Wain CM; Westwick J; Ward SG Cell Signal; 2005 Oct; 17(10):1194-202. PubMed ID: 16038794 [TBL] [Abstract][Full Text] [Related]
33. Fc gamma RIIB1/SHIP-mediated inhibitory signaling in B cells involves lipid rafts. Aman MJ; Tosello-Trampont AC; Ravichandran K J Biol Chem; 2001 Dec; 276(49):46371-8. PubMed ID: 11571279 [TBL] [Abstract][Full Text] [Related]
34. Integration of activatory and inhibitory signals in human B-cells. Sármay G; Koncz G; Gergely J Immunol Lett; 1996 Dec; 54(2-3):93-100. PubMed ID: 9052860 [TBL] [Abstract][Full Text] [Related]
35. The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling. Gary-Gouy H; Bruhns P; Schmitt C; Dalloul A; Daëron M; Bismuth G J Biol Chem; 2000 Jan; 275(1):548-56. PubMed ID: 10617650 [TBL] [Abstract][Full Text] [Related]
36. Autonomous SHIP-dependent FcgammaR signaling in pre-B cells leads to inhibition of cell migration and induction of cell death. Brauweiler AM; Cambier JC Immunol Lett; 2004 Mar; 92(1-2):75-81. PubMed ID: 15081530 [TBL] [Abstract][Full Text] [Related]
37. Fc epsilon receptor I-associated lyn-dependent phosphorylation of Fc gamma receptor IIB during negative regulation of mast cell activation. Malbec O; Fong DC; Turner M; Tybulewicz VL; Cambier JC; Fridman WH; Daëron M J Immunol; 1998 Feb; 160(4):1647-58. PubMed ID: 9469421 [TBL] [Abstract][Full Text] [Related]
38. C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1. Tanigaki K; Mineo C; Yuhanna IS; Chambliss KL; Quon MJ; Bonvini E; Shaul PW Circ Res; 2009 Jun; 104(11):1275-82. PubMed ID: 19423845 [TBL] [Abstract][Full Text] [Related]
39. IgG-Independent Co-aggregation of FcεRI and FcγRIIB Results in LYN- and SHIP1-Dependent Tyrosine Phosphorylation of FcγRIIB in Murine Bone Marrow-Derived Mast Cells. Gast M; Preisinger C; Nimmerjahn F; Huber M Front Immunol; 2018; 9():1937. PubMed ID: 30210494 [TBL] [Abstract][Full Text] [Related]
40. Regulation of phosphoinositide 3-kinase signaling by oxidants: hydrogen peroxide selectively enhances immunoreceptor-induced recruitment of phosphatidylinositol (3,4) bisphosphate-binding PH domain proteins. Cheung SM; Kornelson JC; Al-Alwan M; Marshall AJ Cell Signal; 2007 May; 19(5):902-12. PubMed ID: 17215104 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]